CCM
MEDP icon

Chilton Capital Management’s Medpace MEDP Stock Holding History

Chilton Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13
Closed -$6.24K – 652
2026
Q1 		$6.24K Buy
13
+12
+1,200% +$6.14K ﹤0.01% 522
2025
Q4 		$562 Buy
+1
New +$568 ﹤0.01% 636

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Chilton Capital Management's MEDP Position: Q2 2026 in Review

Chilton Capital Management sold out of Medpace (MEDP) in Q2 2026, closing a stake of 13 shares — an estimated $6.24K sold.

Chilton Capital Management first reported a position in MEDP in Q4 2025 and held it in 2 quarters. The position peaked at $6.24K in Q1 2026. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Chilton Capital Management reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • Chilton Capital Management sold 13 Medpace shares in Q2 2026, an estimated $6.24K.
  • Chilton Capital Management first reported a position in Medpace in Q4 2025 and held it in 2 quarters.
  • Chilton Capital Management's Medpace position peaked at $6.24K in Q1 2026.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Chilton Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.